Health
5 Big Wins in 2021 for Higher Education, Democracy, Climate, Contraceptives, and Evidence-Based Policy
Contraceptive Choice and Access
5 Big Wins in 2021 for Higher Education, Democracy, Climate, Contraceptives, and Evidence-Based Policy
Year in Review
Congress: Pharma's Price Gouging is Purposeful
Drug Prices
Congress: Pharma’s Price Gouging is Purposeful
New Research Points to How to Reduce the $100 Billion Americans Spend Annually on Unnecessary Health Care
Provider Payment Incentives
New Research Points to How to Reduce the $100 Billion Americans Spend Annually on Unnecessary Health Care
Q&A
Video: Health Care is Not a Functioning Market
Commercial Sector Prices
Video: Health Care is Not a Functioning Market
Video Series: Health Care Prices
Complex Care
Fixing the FIDE-SNP — Redefining ‘Fully Integrated’
Maximizing Opportunity, Minimizing Injustice for Our Nation’s Veterans
Drug Prices
Maximizing Opportunity, Minimizing Injustice for Our Nation’s Veterans
Complex Care
Improving Behavioral Health Supports for Dual-Eligible Individuals
Drug Pricing Reform Failure is Unacceptable
Drug Prices
Drug Pricing Reform Failure is Unacceptable
Op-Ed
HCBS Spending Plans and the Untapped Potential of D-SNPs
Complex Care
HCBS Spending Plans and the Untapped Potential of D‑SNPs
How Colorado Passed Sweeping Policies for Wider Contraceptive Choice
Contraceptive Choice and Access
How Colorado Passed Sweeping Policies for Wider Contraceptive Choice
Part 3: After a Groundswell of Success in 2021, Stage is Set for Broader Rx Reform in 2022
Drug Prices
Part 3: After a Groundswell of Success in 2021, Stage is Set for Broader Rx Reform in 2022
Drug Affordability
Part 2: In Quest to Lower Rx Prices, States Deploy New Tools
Drug Prices
Part 2: In Quest to Lower Rx Prices, States Deploy New Tools
Drug Affordability
Part 1: As Congress Debates Lowering Drug Prices, States Waste No Time
Drug Prices
Part 1: As Congress Debates Lowering Drug Prices, States Waste No Time
Drug Affordability
Complex Care
New Resources Enable Investigators to Expand Research into Dual-Eligible Individuals
COVID-19’s Toll Underscores Need to Address Health and Social Needs of Dual-Eligible Individuals
Complex Care
COVID-19’s Toll Underscores Need to Address Health and Social Needs of Dual-Eligible Individuals
Protecting Patients From the Cost of Surprise Billing is Not Finished
Commercial Sector Prices
Protecting Patients From the Cost of Surprise Billing is Not Finished
Home and Community-Based Services: Just One Piece of the Puzzle
Complex Care
Home and Community-Based Services: Just One Piece of the Puzzle
FDA's Pfizer Vaccine Approval is Proof that Public-Private Partnerships Work
Drug Prices
FDA’s Pfizer Vaccine Approval is Proof that Public-Private Partnerships Work
About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.